Clinical trial

A Pilot Biomarker Study Assessing Alpha-synuclein Aggregates Across Biofluid Reservoirs in Patients With Synucleinopathies

NCT04020198

StatusTERMINATED

Study typeOBSERVATIONAL

Start date2020-01-15

PhaseN/A

Study timeline

Study start (actual)2020-01-15Date precision: day

Registry last updated2025-04-06

Observed by CureCurrent2026-10-07

Recorded dates are source observations, not predictions. Missing milestones are not estimated.

Conditions

Parkinson Diseaseunresolved

Multiple System Atrophyunresolved

Rapid Eye Movement Sleep Behavior Disorderunresolved

Normal Pressure Hydrocephalusunresolved

Interventions

Biomarker assayOTHER

Sponsors & collaborators

Stony Brook Universitylead sponsor

Mapped research locations

Stony BrookNew York, United States1

Registry source

Open the source record to verify current eligibility, contacts, locations and registry updates.

Open NCT04020198 on ClinicalTrials.gov ↗

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.